ARYx Therapeutics - Dividend History | ARYX
Historical dividend payout and yield for ARYx Therapeutics (ARYX) since 1971. The current TTM dividend payout for ARYx Therapeutics (ARYX) as of December 31, 1969 is $0.00. The current dividend yield for ARYx Therapeutics as of December 31, 1969 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.000B |
$0.000B |
|
ARYx Therapeutics is a biopharmaceutical company focused on developing a portfolio of internally discovered product candidates designed to eliminate known safety issues associated with well-established, commercially successful drugs. ARYx uses its RetroMetabolic Drug Design(TM) technology to design structurally unique molecules that retain the efficacy of these original drugs but are metabolized through a potentially safer pathway to avoid specific adverse side effects associated with these compounds. ARYx currently has three products in Phase 2 clinical trials: ATI-7505 for the treatment of various gastrointestinal disorders, ATI-5923 for the treatment of patients at risk for the formation of dangerous blood clots, and ATI-2042 for the treatment of atrial fibrillation.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
